Advertisement

Tobacco dependence is associated with increased risk for multi-morbid clustering of posttraumatic stress disorder, depressive disorder, and pain among post-9/11 deployed veterans

  • Jennifer R. FondaEmail author
  • Kristin L. Gregor
  • Catherine B. Fortier
  • Erica R. Scioli-Salter
  • Regina E. McGlinchey
  • Ann Rasmusson
Original Investigation
  • 41 Downloads

Abstract

Rationale

Tobacco use is highly prevalent among individuals with posttraumatic stress disorder (PTSD), depressive disorders, and pain. Research has revealed pairwise relationships among these conditions but has not examined more complex relationships that may influence symptom severity, chronicity, and treatment outcome.

Objective

To examine the clustering of current PTSD, depressive disorders, and clinically significant pain according to current tobacco use and dependence among post-9/11 deployed veterans.

Methods

Logistic regression was used to examine the clustering of these conditions in relationship to current tobacco use/dependence, while adjusting for age and total combat exposure, in 343 post-9/11 deployed veterans enrolled in the Translational Research Center for TBI and Stress Disorders (TRACTS) cohort (Mage = 32.1 + 8.3 years; 38% current tobacco use; 25% low and 12% moderate/high tobacco dependence).

Results

A three-way clustering of PTSD, depressive disorder, and pain was more likely than any single or pairwise combination of these conditions in moderate/high tobacco-dependent veterans compared to tobacco non-users (adjusted ORs = 3.50 to 4.18). This multi-morbidity cluster also was associated with increased PTSD severity.

Conclusions

Moderate to high dependence on tobacco is associated with substantially increased clustering of PTSD, depression, and clinically significant pain in veterans. Research examining synergistic interactions among these conditions, biological vulnerabilities shared among them, and the direct impact of tobacco use on the pathophysiology of PTSD, depression, and pain is needed. The results of such work may spur development of more effective integrated treatments to reduce the negative impact of these multi-morbid conditions on veterans’ wellbeing and long-term health.

Keywords

PTSD comorbidity Tobacco use Pain Depression 

Notes

Acknowledgements

We would like to thank Dr. Vincent Corbo for his contribution to the analysis of the TRACTS childhood trauma data.

Funding information

This work was supported by the VA National Center for PTSD, Women’s Health Science Division, Department of Veteran Affairs; the Translational Research Center for TBI and Stress Disorders (TRACTS), a VA Rehabilitation Research and Development Traumatic Brain Injury National Network Research Center (B9254-C); and a VA Clinical Science Research and Development Merit Review (CX001327).

Compliance with ethical standards

The Institutional Review Board for Human Studies Research at VA Boston Healthcare System (VABHS) approved all study procedures.

Conflicts of interest

Within the past 3 years, Dr. Rasmusson has been a paid consultant for Cohen Veterans Bioscience and Resilience Therapeutics.

References

  1. Agaku IT, King BA, Dube SR (2014) Current cigarette smoking among adults—United States, 2005-2012. Morb Mortal Wkly Rep 63:29–34Google Scholar
  2. Antony MM, Bieling PJ, Cox BJ, Enns MW, Swinson RP (1998) Psychometric properties of the 42-item and 21-item versions of the depression anxiety stress scales in clinical groups and a community sample. Psychol Assess 10:176–181CrossRefGoogle Scholar
  3. Beckham JC, Kirby AC, Feldman ME, Hertzberg MA, Moore SD, Crawford AL, Davidson JRT, Fairbank JA (1997) Prevalence and correlates of heavy smoking in Vietnam veterans with chronic posttraumatic stress disorder. Addict Behav 22:637–647CrossRefGoogle Scholar
  4. Breslau N, Davis GC, Peterson EL, Schultz LR (2000) A second look at comorbidity in victims of trauma: the posttraumatic stress disorder–major depression connection. Biol Psychiatry 48:902–909CrossRefGoogle Scholar
  5. Carpenter VL, Hertzberg JS, Kirby AC, Calhoun PS, Moore SD, Dennis MF, Dennis PA, Dedert EA, Hair LP, Beckham JC (2015) Multi-component smoking cessation treatment including mobile contingency management for smoking cessation in homeless veteran smokers. J Clin Psychiatry 76:959–964CrossRefGoogle Scholar
  6. Centers for Disease Control and Prevention (2018) Office on Smoking and Health’s Interactive Data Dissemination Tool: OSHData. https://www.cdc.gov/oshdata. Accessed 17 November 2018
  7. Corbo V, Salat DH, Amick MM, Leritz EC, Milberg WP, McGlinchey RE (2014) Reduced cortical thickness in veterans exposed to early life trauma. Psychiatry Res 223:53–60CrossRefGoogle Scholar
  8. Cypel YS, Hamlett-Berry K, Barth SK, Christofferson DE, Davey VJ, Eber S, Schneiderman AI, Bossarte RM (2016) Cigarette smoking and sociodemographic, military, and health characteristics of operation enduring freedom and operation Iraqi freedom veterans: 2009-2011 national health study for a new generation of us veterans. Public Health Rep 131:714–727CrossRefGoogle Scholar
  9. Ditre JW, Brandon TH, Zale EL, Meagher MM (2011) Pain, nicotine, and smoking: research findings and mechanistic considerations. Psychol Bull 137:1065–1093CrossRefGoogle Scholar
  10. Dworkin RH, Turk DC, Farrar JT, Haythornthwaite JA, Jensen MP, Katz NP, Kerns RD, Stucki G, Allen RR, Bellamy N, Carr DB, Chandler J, Cowan P, Dionne R, Galer BS, Hertz S, Jadad AR, Kramer LD, Manning DC, Martin S, McCormick CG, McDermott MP, McGrath P, Quessy S, Rappaport BA, Robbins W, Robinson JP, Rothman M, Royal MA, Simon L, Stauffer JW, Stein W, Tollett J, Wernicke J, Witter J (2005) Core outcome measures for chronic pain clinical trials: IMMPACT recommendations. Pain 113:9–19CrossRefGoogle Scholar
  11. Dworkin RH, Turk DC, Peirce-Sandner S, Baron R, Bellamy N, Burke LB, Chappell A, Chartier K, Cleeland CS, Costello A, Cowan P, Dimitrova R, Ellenberg S, Farrar JT, French JA, Gilron I, Hertz S, Jadad AR, Jay GW, Kalliomäki J, Katz NP, Kerns RD, Manning DC, McDermott MP, McGrath PJ, Narayana A, Porter L, Quessy S, Rappaport BA, Rauschkolb C, Reeve BB, Rhodes T, Sampaio C, Simpson DM, Stauffer JW, Stucki G, Tobias J, White RE, Witter J (2010) Research design considerations for confirmatory chronic pain clinical trials: IMMPACT recommendations. Pain 149:177–193CrossRefGoogle Scholar
  12. Epidemiology Program Post-Deployment Health Group (2012) Analysis of VA health care utilization among operation enduring freedom, operation Iraqi freedom, and operation new dawn veterans, from 1st qtr FY 2002 through 1st qtr FY 2012. U.S. Department of Veterans Affairs, Washington DCGoogle Scholar
  13. Familoni BO, Gregor KL, Dodson TS, Krzywicki AT, Lowery BN Jr, Orr SP, Suvak MK, Rasmusson AM (2016) Sweat pore reactivity as a surrogate measure of sympathetic nervous system activity in trauma-exposed individuals with and without posttraumatic stress disorder. Psychophysiology 53:1417–1428CrossRefGoogle Scholar
  14. Fergusson DM, Boden JM, Horwood LJ (2009) Tests of causal links between alcohol abuse or dependence and major depression. Arch Gen Psychiatry 66:260–266CrossRefGoogle Scholar
  15. First M, Spitzer RL, Gibbon M, Williams JB (1997) User’s guide for the structured clinical interview for DSM-IV Axis I disorders—SCID. American Psychiatric Press, Washington DCGoogle Scholar
  16. Fortier CB, Amick MM, Grande L, McGlynn S, Kenna A, Morra L, Clark A, Milberg WP, McGlinchey RE (2014) The Boston assessment of traumatic brain injury–lifetime (BAT-L) semistructured interview: evidence of research utility and validity. J Head Trauma Rehabil 29(89):89–98CrossRefGoogle Scholar
  17. Fu SS, McFall M, Saxon AJ, Beckham JC, Carmody TP, Baker DG, Joseph AM (2007) Post-traumatic stress disorder and smoking: a systematic review. Nicotine Tob Res 9:1071–1084CrossRefGoogle Scholar
  18. Galatzer-Levy IR, Nickerson A, Litz BT, Marmar CR (2013) Patterns of lifetime PTSD comorbidity: a latent class analysis. Depress Anxiety 30:489–496CrossRefGoogle Scholar
  19. Gfroerer J, Dube SR, King BA, Garrett BE, Babb S, McAfee T (2013) Vital signs: current cigarette smoking among adults aged ≥18 years with mental illness—United States, 2009–2011. Morb Mortal Wkly Rep 62:81Google Scholar
  20. Glickman ME, Rao SR, Schultz MR (2014) False discovery rate control is a recommended alternative to Bonferroni-type adjustments in health studies. J Clin Epidemiol 67:850–857CrossRefGoogle Scholar
  21. Grichnik K, Ferrante F (1991) The difference between acute and chronic pain. Mt Sinai J Med 58:217–220PubMedGoogle Scholar
  22. Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom KO (1991) The Fagerström test for nicotine dependence: a revision of the Fagerstrom tolerance questionnaire. Br J Addict 86:1119–1127CrossRefGoogle Scholar
  23. Hoge CW, Castro CA, Messer SC, McGurk D, Cotting DI, Koffman RL (2004) Combat duty in Iraq and Afghanistan, mental health problems. and barriers to care NEJM 351:13–22PubMedGoogle Scholar
  24. Hoge CW, McGurk D, Thomas JL, Cox AL, Engel CC, Castro CA (2008) Mild traumatic brain injury in US soldiers returning from Iraq. NEJM 358:453–463CrossRefGoogle Scholar
  25. Hooten WM, Shi Y, Gazelka HM, Warner DO (2011) The effects of depression and smoking on pain severity and opioid use in patients with chronic pain. Pain 152:223–229CrossRefGoogle Scholar
  26. Hosseinzadeh A, Thompson PR, Segal BH, Urban CF (2016) Nicotine induces neutrophil extracellular traps. J Leukoc Biol 100:1105–1112CrossRefGoogle Scholar
  27. Izumi Y, O'Dell KA, Zorumski CF (2013) Metaplastic LTP inhibition after LTD induction in CA1 hippocampal slices involves NMDA receptor-mediated neurosteroidogenesis. Physiol Rep 1Google Scholar
  28. Jamal A, Phillips E, Gentzke AS, Homa DM, Babb SD, King BA, Neff LJ (2018) Current cigarette smoking among adults—United States, 2016. Morb Mortal Wkly Rep 67(53)Google Scholar
  29. Japuntich SJ, Gregor K, Pineles SL, Gradus JL, Street AE, Prabhala R, Rasmusson AM (2016) Deployment stress, tobacco use, and postdeployment posttraumatic stress disorder: gender differences. Psychol Trauma 8:123–126CrossRefGoogle Scholar
  30. Kaminska M, Harris J, Gijsbers K, Dubrovsky B (2000) Dehydroepiandrosterone sulfate (DHEAS) counteracts decremental effects of corticosterone on dentate gyrus LTP. Implications for depression Brain Res Bull 52:229–234CrossRefGoogle Scholar
  31. Karp JF, Scott J, Houck P, Kupfer D, Frank E (2005) Pain predicts longer time to remission during treatment of recurrent depression. J Clin Psychiatry 66:591–597CrossRefGoogle Scholar
  32. Kessler RC, Sonnega A, Bromet E, Hughes M, Nelson CB (1995) Posttraumatic stress disorder in the National Comorbidity Survey. Arch Gen Psychiatry 52:1048–1060CrossRefGoogle Scholar
  33. King LA, King DW, Vogt DS, Knight J, Samper RE (2006) Deployment risk and resilience inventory: a collection of measures for studying deployment-related experiences of military personnel and veterans. Mil Psychol 18:89–120CrossRefGoogle Scholar
  34. Koenen KC, Hitsman B, Lyons MJ, Niaura R, McCaffery J, Goldberg J, Eisen SA, True W, Tsuang M (2005) A twin registry study of the relationship between posttraumatic stress disorder and nicotine dependence in men. Arch Gen Psychiatry 62:1258–1265CrossRefGoogle Scholar
  35. Kubany ES, Leisen MB, Kaplan AS, Watson SB, Haynes SN, Owens JA, Burns K (2000) Development and preliminary validation of a brief broad-spectrum measure of trauma exposure: the traumatic life events questionnaire. Psychol Assess 12:210–224CrossRefGoogle Scholar
  36. Lasser K, Boyd JW, Woolhandler S, Himmelstein DU, McCormick D, Bor DH (2000) Smoking and mental illness: a population-based prevalence study. JAMA 284:2606–2610CrossRefGoogle Scholar
  37. Leonard S, Adler LE, Benhammou K, Berger R, Breese CR, Drebing C, Gault J, Lee MJ, Logel J, Olincy A, Ross RG, Stevens K, Sullivan B, Vianzon R, Virnich DE, Waldo M, Walton K, Freedman R (2001) Smoking and mental illness. Pharmacol Biochem Behav 70:561–570CrossRefGoogle Scholar
  38. Lew HL, Otis JD, Tun C, Kerns RD, Clark ME, Cifu DX (2009) Prevalence of chronic pain, posttraumatic stress disorder, and persistent postconcussive symptoms in OIF/OEF veterans: polytrauma clinical triad. J Rehabil Res Dev 46:697–702CrossRefGoogle Scholar
  39. McFall M, Saxon AJ, Thaneemit-Chen S, Smith MW, Joseph AM, Carmody TP, Beckham JC, Malte CA, Vertrees JE, Boardman KD, Lavori PW (2007) Integrating smoking cessation into mental health care for post-traumatic stress disorder. Clin Trials 4:178–189CrossRefGoogle Scholar
  40. McGlinchey RE, Milberg WP, Fonda JR, Fortier CB (2017) A methodology for assessing deployment trauma and its consequences in OEF/OIF/OND veterans: the TRACTS longitudinal prospective cohort study. Int J Methods Psychiatr Res 26:e1556CrossRefGoogle Scholar
  41. Melzack R (1987) The short-form McGill pain questionnaire. Pain 30:191–197CrossRefGoogle Scholar
  42. Miller AH, Raison CL (2016) The role of inflammation in depression: from evolutionary imperative to modern treatment target. Nat Rev Immunol 16(22):22–34CrossRefGoogle Scholar
  43. Neria Y, Nandi A, Galea S (2008) Post-traumatic stress disorder following disasters: a systematic review. Psychol Med 38:467–480CrossRefGoogle Scholar
  44. Patterson AL, Gritzner S, Resnick MP, Dobscha SK, Turk DC, Morasco BJ (2012) Smoking cigarettes as a coping strategy for chronic pain is associated with greater pain intensity and poorer pain-related function. J Pain 13:285–292CrossRefGoogle Scholar
  45. Pitman RK, Rasmusson AM, Koenen KC, Shin LM, Orr SP, Gilbertson MW, Milad MR, Liberzon I (2012) Biological studies of post-traumatic stress disorder. Nat Rev Neurosci 13:769–787CrossRefGoogle Scholar
  46. Rasmusson A, Wu R, Paliwal P, Anderson G, Krishnan-Sarin S (2006a) Smoking abstinence-induced decreases in the ratio of plasma DHEA to cortisol may predict smoking relapse. A preliminary study Psychopharmacology 186:473–480CrossRefGoogle Scholar
  47. Rasmusson AM, Picciotto MR, Krishnan-Sarin S (2006b) Smoking as a complex but critical covariate in neurobiological studies of posttraumatic stress disorders: a review. J Psychopharmacol 20:693–707CrossRefGoogle Scholar
  48. Rasmusson AM, Pineles SL (2018) Neurotransmitter, peptide, and steroid hormone abnormalities in PTSD: biological Endophenotypes relevant to treatment. Curr Psychiatry Rep 20(52):52CrossRefGoogle Scholar
  49. Rasmusson AM, Vythilingam M, Morgan CA (2003) The neuroendocrinology of posttraumatic stress disorder: new directions. CNS Spectr 8:651–667CrossRefGoogle Scholar
  50. Riley JL, King C (2009) Self-report of alcohol use for pain in a multi-ethnic community sample. J Pain 10:944–952CrossRefGoogle Scholar
  51. Room R (2004) Smoking and drinking as complementary behaviours. Biomed Pharmacother 58:111–115CrossRefGoogle Scholar
  52. Rosa C, Ghitza U, Tai B (2012) Selection and utilization of assessment instruments in substance abuse treatment trials: the National Drug Abuse Treatment Clinical Trials Network experience. Subst Abuse Rehabil 3(81)Google Scholar
  53. Rothman KJ, Greenland S, Lash TL (2008) Modern epidemiology, 3rd edn. Lippincott Williams and Wilkins, PhiladelphiaGoogle Scholar
  54. Salisbury C, Johnson L, Purdy S, Valderas JM, Montgomery AA (2011) Epidemiology and impact of multimorbidity in primary care: a retrospective cohort study. Br J Gen Pract 61:e12–e21CrossRefGoogle Scholar
  55. Sandi C (2011) Glucocorticoids act on glutamatergic pathways to affect memory processes. Trends Neurosci 34:165–176CrossRefGoogle Scholar
  56. Scioli-Salter E, Forman DE, Otis JD, Tun C, Allsup K, Marx CE, Hauger RL, Shipherd JC, Higgins D, Tyzik A, Rasmusson AM (2016) Potential neurobiological benefits of exercise in chronic pain and posttraumatic stress disorder: pilot study. J Rehabil Res Dev 53:95–106CrossRefGoogle Scholar
  57. Scioli-Salter ER, Forman DE, Otis JD, Gregor K, Valovski I, Rasmusson AM (2015) The shared neuroanatomy and neurobiology of comorbid chronic pain and PTSD: therapeutic implications. Clin J Pain 31:363–374CrossRefGoogle Scholar
  58. Skinner HA, Sheu W-J (1982) Reliability of alcohol use indices. The lifetime drinking history and the MAST. J Stud Alcohol 43:1157–1170CrossRefGoogle Scholar
  59. Tanielian TL, Jaycox L (2008) Invisible wounds of war: psychological and cognitive injuries, their consequences, and services to assist recovery, vol 1. Rand Corporation, ArlingtonGoogle Scholar
  60. Tibuakuu M, Kamimura D, Kianoush S, DeFilippis AP, al Rifai M, Reynolds LM, White WB, Butler KR, Mosley TH, Turner ST, Kullo IJ, Hall ME, Blaha MJ (2017) The association between cigarette smoking and inflammation: the genetic epidemiology network of Arteriopathy (GENOA) study. PLoS One 12:e0184914CrossRefGoogle Scholar
  61. U.S. Department of Health & Human Services (2015) Subtance Abuse and Mental Health Services Administration. https://www.samhsa.gov/disorders/substance-use. Accessed 8 June 2018
  62. U.S. National Institute on Drug Abuse (1999) National Institute of Drug Abuse (NIDA) Clinical Trials Network (CTN) Common Data Elements. https://cde.drugabuse.gov/. Accessed 15 November 2018
  63. Uijen AA, van de Lisdonk EH (2008) Multimorbidity in primary care: prevalence and trend over the last 20 years. Euro J Gen Pract 14:28–32CrossRefGoogle Scholar
  64. Weathers FW, Ruscio AM, Keane TM (1999) Psychometric properties of nine scoring rules for the clinician-administered posttraumatic stress disorder scale. Psychol Assess 11:124–133CrossRefGoogle Scholar
  65. Weiss J, McEwen B, Silva M, Kalkut M (1970) Pituitary-adrenal alterations and fear responding. Am J Phys 218:864–868Google Scholar
  66. Widome R, Joseph AM, Polusny MA, Chlebeck B, Brock B, Gulden A, Fu SS (2011) Talking to Iraq and Afghanistan war veterans about tobacco use. Nicotine Tob Res 13:623–626CrossRefGoogle Scholar

Copyright information

© This is a U.S. government work and not under copyright protection in the U.S.; foreign copyright protection may apply 2018 2019

Authors and Affiliations

  1. 1.Geriatric Research, Education and Clinical Center (GRECC) and Translational Research Center for TBI and Stress Disorders (TRACTS), VA Boston Healthcare SystemBostonUSA
  2. 2.Department of PsychiatryHarvard Medical SchoolBostonUSA
  3. 3.VA Boston Healthcare SystemBostonUSA
  4. 4.National Center for PTSD, Women’s Health Sciences Division, Dept. of Veterans AffairsBostonUSA
  5. 5.Department of PsychiatryBoston University School of MedicineBostonUSA

Personalised recommendations